Published in PLoS One on April 15, 2015
Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis. Lancet Psychiatry (2017) 0.80
Utility of Washington Early Recognition Center Self-Report Screening Questionnaires in the Assessment of Patients with Schizophrenia and Bipolar Disorder. Front Psychiatry (2016) 0.75
The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull (1987) 51.07
The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat (1992) 29.45
Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol (1967) 22.39
The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry (1976) 15.48
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Adverse health effects of non-medical cannabis use. Lancet (2009) 6.25
Exploring the association between cannabis use and depression. Addiction (2003) 2.92
Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry (2005) 2.14
Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use. Arch Gen Psychiatry (2004) 1.60
Δ9-THC-caused synaptic and memory impairments are mediated through COX-2 signaling. Cell (2013) 1.58
Severity classification on the Hamilton Depression Rating Scale. J Affect Disord (2013) 1.55
Quantifying the clinical significance of cannabis withdrawal. PLoS One (2012) 1.19
Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophr Bull (2009) 1.17
An examination of self-medication and rebound effects: Psychiatric symptomatology before and after alcohol or drug relapse. Addict Behav (2005) 1.17
The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol Med (2014) 1.16
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos Trans R Soc Lond B Biol Sci (2012) 1.15
[Validation of positive and negative symptom scale (PANSS) in a sample of Spanish schizophrenic patients]. Actas Luso Esp Neurol Psiquiatr Cienc Afines (1995) 1.11
Testing the self-medication hypothesis of depression and aggression in cannabis-dependent subjects. Psychol Med (2007) 1.10
[Validation of the Castillian version of the Hamilton Rating Scale for Depression]. Actas Luso Esp Neurol Psiquiatr Cienc Afines (1986) 1.04
Psychological pathways to depression in schizophrenia: studies in acute psychosis, post psychotic depression and auditory hallucinations. Eur Arch Psychiatry Clin Neurosci (2005) 1.00
Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study. PLoS One (2013) 0.98
Impact of cannabis and other drugs on age at onset of psychosis. J Clin Psychiatry (2008) 0.98
Cannabis use and first-episode psychosis: relationship with manic and psychotic symptoms, and with age at presentation. Psychol Med (2013) 0.97
Substance use disorders and comorbid Axis I and II psychiatric disorders among young psychiatric patients: findings from a large electronic health records database. J Psychiatr Res (2011) 0.96
The predictors and consequences of adolescent amphetamine use: findings from the Victoria Adolescent Health Cohort Study. Addiction (2007) 0.96
Anxiety and depression in psychosis: a systematic review of associations with positive psychotic symptoms. Acta Psychiatr Scand (2013) 0.95
Decreased depression in marijuana users. Addict Behav (2005) 0.90
Reasons for cannabis use in psychosis. Aust N Z J Psychiatry (2006) 0.89
Dose-response effect between cannabis use and psychosis liability in a non-clinical population: evidence from a snowball sample. J Psychiatr Res (2013) 0.86
The evolution of depression and suicidality in first episode psychosis. Acta Psychiatr Scand (2009) 0.86
Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people. J Psychiatr Res (2013) 0.86
Depression and depressive symptoms in first episode psychosis. J Nerv Ment Dis (2010) 0.85
Depressive symptoms in first episode schizophrenia spectrum disorder. Schizophr Res (2011) 0.85
Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial. Psychol Med (2013) 0.85
A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophr Res (2012) 0.85
Cannabis use as an indicator of risk for mental health problems in adolescents: a population-based study at secondary schools. Psychol Med (2012) 0.84
Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene. Addict Biol (2011) 0.84
The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS). J Psychiatr Res (2013) 0.83
A comparison of psychosocial and cognitive functioning between depressed and non-depressed patients with cannabis dependence. J Addict Dis (2010) 0.83
The endocannabinoid system and emotional processing: a pharmacological fMRI study with ∆9-tetrahydrocannabinol. Eur Neuropsychopharmacol (2013) 0.82
Does change in cannabis use in established psychosis affect clinical outcome? Schizophr Bull (2011) 0.80
Depressive symptoms in first episode psychosis: a one-year follow-up study. BMC Psychiatry (2013) 0.80
Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis. J Psychiatr Res (2009) 0.80
Reasons for substance use and their relationship to subclinical psychotic and affective symptoms, coping, and substance use in a nonclinical sample. Psychol Addict Behav (2013) 0.77
Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol. World J Biol Psychiatry (2011) 0.77
Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis. Schizophr Res (2013) 0.76